Patient Care

The grant supports the launch of a natural history study for a rare neurodevelopmental disorder that causes developmental delays and seizures. 

Dr. Jennifer Downs of Weill Cornell Medicine has spent much of her career in Tanzania, searching for a treatment for schistosomiasis, an acute, chronic parasitic worm infection that affects more than 250 million people worldwide.

Experts in newest treatment option for cancer, neurological disorders unite to speed progress, expand access.

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego.

The Weill Award recognizes an exceptional faculty member whose transformational work enhances health care worldwide. 

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

Dr. Arnab Ghosh, assistant professor of medicine at Weill Cornell Medicine, has been selected as an Emerging Leader in Health and Medicine Scholar.

Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center are expanding the understanding of how the BCG treatment for early bladder cancer works.

Weill Cornell Medicine is fostering a new generation of researchers in Tanzania, with implications for improved health care outcomes worldwide.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian that compared the safety and efficacy of the injectable drugs. 

Weill Cornell Medicine has received a projected $4 million grant from the National Cancer Institute, part of the National Institutes of Health, to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.

Teams of health care providers called Accountable Care Organizations participating in the Medicare Shared Savings Program have saved Medicare between $4.1 billion and $8.1 billion from 2012 through 2019, according to a new study from Weill Cornell Medicine investigators. 

Weill Cornell Medicine investigators are developing a new test for TB that circumvents many of the current diagnostic challenges.

Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center investigators.

At Weill Cornell Medical College, students have a new tool for polishing their bedside manner and making a diagnosis: an artificial intelligence-powered virtual patient that simulates the doctor-patient interaction.

Students from Cornell’s Master of Public Health program and faculty from Weill Cornell Medicine’s Department of Pediatrics recently joined forces at the United Nations Foundation’s Shot@Life Advocate to Vaccinate Summit to champion global vaccine access.

A generous grant from The Hearst Foundations will fund a new Program for the Study and Support of Caregivers at Weill Cornell Medicine, developing new strategies to help people cope with the challenges of caring for friends or family members at home.

Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education.

The Weill Cornell Medicine Program for Substance Use and Stigma of Addiction has proudly distributed naloxone rescue kits (Narcan) to the New York City community for 10 years.